CMP vs Fascia Iliaca Block

Study Overview
=================
Brief Summary
-----------------
Complete motorsparing protocol (CMP) has been developed to try to minimize the motor nerve block that is created when using Facia iliaca nerve block. The blocks performed in the (CMP) are the cluneal nerve block, Pericapsular nerve group block and lateral femoral cutaneous block. On the clinical trial, the investigators will randomize the participants that meet criteria to CMP or Fascia iliaca Block and compare the amount of opioid needed post op during 24 hours and their pain scores.

Official Title
-----------------
Complete Motor Sparing Protocol Versus Fascia Iliaca Suprainguinal Technique for Total Hip Arthroplasty, a Prospective Randomized Clinical Trial.

Conditions
-----------------
Pain, Postoperative, Hip Arthroplasty

Intervention / Treatment
-----------------
* Drug: CMP
* Drug: Fascia Illica


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients ≥ 18 years old Patients undergoing total hip arthroplasty posterior approach. Patients willing to participate and sign informed consent Exclusion Criteria: Severe COPD/other contraindication to general anesthesia that spinal would be more suitable. Patient with a weight of less than 41 kg Dementia, not alert or Oriented to person, place, or time Chronic pain patient with daily opioid use at home. Patient with allergy to local anesthetics Patient refusal Total hip arthroplasty revision Concomitant pain in different area from operative site. Pregnancy Patient with active infection on the injection sites for the blocks Patients unable or willing to understand or comply with the study protocol

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: CMP<br>Cluneal nerve Block 0.25% bupivacaine 20ml Pericapsular Nerve group block 0.25% Bupivacaine 20ml Lateral femoral cutaneous Block 0.25% bupivacaine 10ml | Drug: CMP<br>* Cluneal nerve Block 0.25% bupivacaine 20ml Pericapsular Nerve group block 0.25% Bupivacaine 20ml Lateral femoral cutaneous Block 0.25% bupivacaine 10ml<br>|
| Active Comparator: Fascia iliaca<br>Fascia iliaca block suprainguinal technique 0.25% bupivacaine 50ml | Drug: Fascia Illica<br>* Fascia iliaca block suprainguinal technique 0.25% bupivacaine 50ml<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Measurement of opioid use | Measurement of opioid use (mg) for pain control after surgery once patient in recovery area | 24 hours | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Measurement of the pain control | Measurement of the pain control via numeric rating scale 0-10 where 0 is no pain and 10 is the worst pain. | 24 hours | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Nerve Block, Fascia Iliaca Nerve Block, Complete Motor Sparing Protocol, Hip Arthroplasty, Pain control